Stock Market Today: Dow Sinks 500 Points as Trump’s Tariff Threats Cause Turmoil
US Consumer Sentiment Flat, Job Worries Weigh on Outlook
US consumer sentiment remained depressed in October, highlighting the strain of ongoing inflation and growing concerns about the labor market.
Stock Market Today: Stocks Slip From Records as Gold Hits $4,000 and Shutdown Drags On
Business & Market Movers
Stock Market Today: Stocks Retreat From Records With Fed Cuts, Earnings Season in Spotlight
·Oct 09, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Harrow’s MELT Acquisition Could Disrupt IV Sedation—But Is It The Hottest Pharma Small-Cap Buy?
Harrow Inc. targets Melt Pharma buyout to expand sedation portfolio with MELT-300, a sublingual non-IV sedative, aiming for U.S. launch and global partnerships while diversifying beyond ophthalmics.
Zepp Health’s Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Merck’s $10 Billion Bet On Verona: Smart Strategic Pivot Or Costly Diversion From The Keytruda Cliff?
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
AMD Soars on Game-Changing Multibillion-Dollar Deal With OpenAI
Shares of Advanced Micro Devices (AMD) soared sky-high on Monday after the chipmaker revealed a game-changing partnership with OpenAI that cements its role as a key rival to Nvidia in the high-stakes AI race.
Elutia’s Game-Changing Tech Has Boston Scientific’s Full Attention— Is A Bigger Deal Coming Next?
